盐酸曲唑酮缓释片在健康受试者中单中心、开放、随机、单剂量、双周期、双交叉空腹和餐后状态下的生物等效性试验
[Translation] A single-center, open-label, randomized, single-dose, two-period, double-crossover bioequivalence study of trazodone hydrochloride extended-release tablets in healthy subjects under fasting and fed conditions
主要目的:比较空腹和餐后给药条件下,沈阳欣瑞制药有限公司生产的盐酸曲唑酮缓释片(150mg)与Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A持证的盐酸曲唑酮缓释片(150mg,商品名:TRITTICO)在健康成年人群中吸收程度和速度的差异,评价其生物等效性。
主要目的:评价空腹和餐后给药条件下,沈阳欣瑞制药有限公司生产的盐酸曲唑酮缓释片(150mg)与Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A持证的盐酸曲唑酮缓释片(150mg,商品名:TRITTICO)在健康成年人群中的安全性。
[Translation] Main purpose: To compare the trazodone hydrochloride sustained-release tablets (150mg) produced by Shenyang Xinrui Pharmaceutical Co., Ltd. and the licensed trazodone hydrochloride sustained-release tablets (Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A.) under fasting and postprandial administration conditions. 150 mg, trade name: TRITTICO) in healthy adults, to evaluate its bioequivalence.
Main purpose: To evaluate the efficacy of trazodone hydrochloride sustained-release tablets (150 mg) produced by Shenyang Xinrui Pharmaceutical Co., Ltd. and Aziende Chimiche Riunite Angelini Francesco-A.C.R.A.F.S.p.A's licensed trazodone hydrochloride sustained-release tablets ( 150 mg, trade name: TRITTICO) in healthy adults.
100 Clinical Results associated with Shenyang Xinrui Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Shenyang Xinrui Pharmaceutical Co., Ltd.
100 Deals associated with Shenyang Xinrui Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Shenyang Xinrui Pharmaceutical Co., Ltd.